Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Revenue: 2020-2024

Historic Revenue for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to $42.1 million.

  • Tango Therapeutics' Revenue rose 363.61% to $53.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.5 million, marking a year-over-year increase of 53.28%. This contributed to the annual value of $42.1 million for FY2024, which is 15.17% up from last year.
  • Tango Therapeutics' Revenue amounted to $42.1 million in FY2024, which was up 15.17% from $36.5 million recorded in FY2023.
  • Tango Therapeutics' 5-year Revenue high stood at $42.1 million for FY2024, and its period low was $7.7 million during FY2020.
  • Its 3-year average for Revenue is $34.5 million, with a median of $36.5 million in 2023.
  • In the last 5 years, Tango Therapeutics' Revenue surged by 383.83% in 2021 and then plummeted by 32.89% in 2022.
  • Tango Therapeutics' Revenue (Yearly) stood at $7.7 million in 2020, then spiked by 383.83% to $37.0 million in 2021, then plummeted by 32.89% to $24.9 million in 2022, then skyrocketed by 46.93% to $36.5 million in 2023, then increased by 15.17% to $42.1 million in 2024.